192 related articles for article (PubMed ID: 35511888)
1. Cost-effectiveness of internet-supported cognitive behavioral therapy for university students with anxiety symptoms: A Markov-model analysis.
You JHS; Luk SWC; Chow DYW; Jiang X; Mak ADP; Mak WWS
PLoS One; 2022; 17(5):e0268061. PubMed ID: 35511888
[TBL] [Abstract][Full Text] [Related]
2. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
[TBL] [Abstract][Full Text] [Related]
3. Cost Effectiveness of Cognitive Behavioral Therapy for the Treatment of Subjective Tinnitus in Australia.
Patel N; Malicka AN; McGinnity S; Anderson RB; Paolini AG; Crosland P
Ear Hear; 2022; 43(2):507-518. PubMed ID: 34456302
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome.
Sampaio F; Bonnert M; Olén O; Hedman E; Lalouni M; Lenhard F; Ljótsson B; Ssegonja R; Serlachius E; Feldman I
BMJ Open; 2019 Jan; 9(1):e023881. PubMed ID: 30679293
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial.
Witlox M; Kraaij V; Garnefski N; Bohlmeijer E; Smit F; Spinhoven P
PLoS One; 2022; 17(1):e0262220. PubMed ID: 35081130
[TBL] [Abstract][Full Text] [Related]
6. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept.
Moayeri F; Dunt D; Hsueh YA; Doyle C
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):331-340. PubMed ID: 30324818
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of alternative treatments for depression in low-income women.
Beil H; Beeber LS; Schwartz TA; Lewis G
J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
[TBL] [Abstract][Full Text] [Related]
9. EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong - A cost-effectiveness analysis.
You JHS; Cho WCS; Ming WK; Li YC; Kwan CK; Au KH; Au JS
PLoS One; 2021; 16(3):e0247860. PubMed ID: 33647045
[TBL] [Abstract][Full Text] [Related]
10. Screening and Treatment of Posttraumatic Stress Disorder in Wildfire Evacuees: A Cost-Utility Analysis.
Lebenbaum M; Hassan SA
MDM Policy Pract; 2024; 9(1):23814683241260423. PubMed ID: 38904072
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial.
Creswell C; Violato M; Fairbanks H; White E; Parkinson M; Abitabile G; Leidi A; Cooper PJ
Lancet Psychiatry; 2017 Jul; 4(7):529-539. PubMed ID: 28527657
[TBL] [Abstract][Full Text] [Related]
12. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
[TBL] [Abstract][Full Text] [Related]
13. Internet-delivered cognitive behavior therapy versus treatment as usual for anxiety and depression among Latin American university students: A randomized clinical trial.
Benjet C; Albor Y; Alvis-Barranco L; Contreras-Ibáñez CC; Cuartas G; Cudris-Torres L; González N; Cortés-Morelos J; Gutierrez-Garcia RA; Medina-Mora ME; Patiño P; Vargas-Contreras E; Cuijpers P; Gildea SM; Kazdin AE; Kennedy CJ; Luedtke A; Sampson NA; Petukhova MV; Zainal NH; Kessler RC
J Consult Clin Psychol; 2023 Dec; 91(12):694-707. PubMed ID: 38032621
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
[TBL] [Abstract][Full Text] [Related]
15. Cost and Effectiveness of Blended Versus Standard Cognitive Behavioral Therapy for Outpatients With Depression in Routine Specialized Mental Health Care: Pilot Randomized Controlled Trial.
Kooistra LC; Wiersma JE; Ruwaard J; Neijenhuijs K; Lokkerbol J; van Oppen P; Smit F; Riper H
J Med Internet Res; 2019 Oct; 21(10):e14261. PubMed ID: 31663855
[TBL] [Abstract][Full Text] [Related]
16. Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up.
Romijn G; Batelaan N; Koning J; van Balkom A; de Leeuw A; Benning F; Hakkaart van Roijen L; Riper H
PLoS One; 2021; 16(11):e0259493. PubMed ID: 34767575
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a Telemonitoring Program for Patients With Heart Failure During the COVID-19 Pandemic in Hong Kong: Model Development and Data Analysis.
Jiang X; Yao J; You JH
J Med Internet Res; 2021 Mar; 23(3):e26516. PubMed ID: 33656440
[TBL] [Abstract][Full Text] [Related]
18. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
[TBL] [Abstract][Full Text] [Related]
19. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
20. Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong.
You JHS; Ming WK; Lee CF; Tsang OT; Chan PK
Vaccine; 2018 Jul; 36(31):4610-4620. PubMed ID: 29958739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
